References | Year of publication | Study design | Country | Patients groups | ART used | Sample size | Number of Treatment failure |
---|---|---|---|---|---|---|---|
Babo et al. [34] | 2017 | Case-control study | Ethiopia | Adult | Stavudine vs. Zidovudine Nevirapine vs. Efavirenz | 307 | 230 |
Bayu et al. [35] | 2017 | Case-control study | Ethiopia | Adults aged ≥ 15 years | D4T-based AZT-based TDF-based | 306 | 160 |
Bilcha et al. [36] | 2019 | Retrospective cohort study | Ethiopia | Adult | Nevirapine-based Efavirenz-based | 396 | 47 |
Bisson et al. [37] | 2008 | Case-control study | Botswana | Adults older than 18 years | NR | 302 | 247 |
Fatti et al. [38] | 2019 | Prospective cohort study | South Africa | Adults aged ≥ 18 years | NRTI and NNRTI | 1901 | 60 |
Ford et al. [39] | 2010 | Observational cohort | South Africa | Adult | EFV, NVP, and other | 207 | 32 |
Gunda et al. [40] | 2019 | Case-control study | Tanzania | Adult | AZT/3TC/EFV, AZT/3TC/NVP, D4T/3TC/NVP, TDF/3TC/EFV | 197 | 24 |
Haile et al. [41] | 2016 | Retrospective cohort study | Ethiopia | Adult (≥ 15 years old) | 1a(d4T + 3TC + NVP), 1b(d4T + 3TC + EFV), 1c(AZT + 3TC + NVP), 1d(AZT + 3TC + EFV), 1e(TDF + 3TC + EFV), 1f(TDF + 3TC + NVP) | 4809 | 113 |
Hailu et al. [42] | 2018 | Retrospective follow-up study | Ethiopia | Adults (≥ 20 years) | TDF 3TCEFV/NVP, AZT 3TC NVP/EFV, D4T 3TC NVP/EFV, ABC 3TC EFV | 260 | 30 |
Hassan et al. [14] | 2014 | Cross-sectional study | Kenya | Adult | Zidovudine-based and Stavudine-based | 232 | 57 |
Izudi et al. [43] | 2016 | Retrospective cohort | Uganda | Adult | 383 | 28 | |
Karade et al. [44] | 2016 | Cross-sectional studies | India | Adult | AZT + 3TC + NVP, AZT + 3TC + EFV TDF + 3TC + NVP, TDF + 3TC + EFV d4T + 3TC + NVP/EFV | 844 | 104 |
Lay et al. [45] | 2017 | Retrospective cohort study | Cambodia | Adult (≥ 18 years old) | d4T/3TC/EFV, d4T/3TC/NVP AZT/3TC/EFV, AZT/3TC/NVP Other | 3581 | 137 |
Ndahimana et al. [46] | 2016 | Retrospective cohort | Rwanda | 15 years and older | NRTIs, NNRTIs, and PIs | 828 | 70 |
Ahmed et al. [47] | 2019 | Case-control study | Ethiopia | Adult | d4t + 3TC + NVP, AZT + 3TC + NVP AZT + 3TC + EFV, TDF + 3TC + EFV TDF + 3TC + NVP | 308 | 199 |